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Abstract
The crucial factor of septic shock and subsequent multiple organ failure is the contamination of circulating blood with a bacterial
endotoxin. The most straightforward approach to mitigating this condition is to remove the endotoxin from the bloodstream.
The hydrophobic Spherocel S80 sorbent has been used as an experimental one in the present work. It was synthesized on the
basis of regenerated cellulose. The dynamic characteristics of endotoxin interactions with the hydrophobic sorbent under flow
conditions were studied using chromatographic columns of different sizes. The effects of the rate and perfusion duration on LPS
binding by Spherocel S80 were evaluated. The endotoxin quantity in every taken sample of the perfusate was determined through
a chromogenic LAL test.
The implemented process showed that the sorbent Spherocel S80 proved successful under flow conditions due to its selective,
capacitive, and hydrodynamic characteristics. Moreover, the sorbent was as efficient in LPS elimination as the conventional ones,
ensuring the required degree of LPS elimination both in biotechnological preparations and biological liquids.
Copyright © 2015, St. Petersburg Polytechnic University. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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formidable medical problem. Studies carried out in
twenty countries worldwide confirm that the incidences
of septic complications of infections are associated with
high death rates and tend to increase despite all ad-
vances in developing novel antibacterial drugs with
broader ranges of activity and techniques for resuscita-
tion, intensive care, and extracorporeal blood treatment.∗ Corresponding author.
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(Peer review under responsibility of St. Petersburg Polytechnic University).Sepsis progresses to septic shock in 58% of cases, and
sepsis-associated death rates range, according to differ-
ent estimates, from 20% to 50% [1].
The main factor of septic shock and subsequent mul-
tiple organ failure is the contamination of circulating
blood with a bacterial endotoxin. The most straightfor-
ward approach to mitigating this condition is to remove
the endotoxin from the bloodstream.
An endotoxin is essentially a lipopolysaccharide
(LPS) of the cell wall of Gram-negative bacteria. The
biological effects of endotoxin were first described by
Richard Pfeiffer who discovered it in 1892. Endotoxin
attacks almost all components of blood homeostasis byion and hosting by Elsevier B.V. This is an open access article under
0/).
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trolled, this activation develops into a severe inflamma-
tory response, eventually resulting in heavy intoxication
and multiple organ failure.
The factors believed to promote systemic endo-
toxemia include antibacterial therapy with bacterici-
dal drugs, damage to natural protective barriers of the
body, slowing down or shunting of the portal circu-
lation, which results in compromising the detoxifying
functions of the liver, and impaired clearing functions
of the lungs and kidneys. However, the selective elimi-
nation of the triggering factors of systemic endotoxemia
is still a promising approach to prevention or, at least, at-
tenuation of the stimulated generation of inflammatory
mediators [2].
In Russia, the experience of plasmapheresis using
columns filled with agents able to selectively bind en-
dotoxin is limited to sporadic attempts to treat patients
with severe septic complications [3]. Dedicated instru-
ments and specific sorbents used in such procedures are
exported from abroad. The performance of original Rus-
sian products is low, making them uncompetitive.
Taken together, the above gives reason to believe that
the development of an efficient sorbent for endotoxin
elimination is expedient.
The objective of the present work is to evaluate the
performance of the hemocompatible sorbent Spherocel
S80 as a means of endotoxin elimination from thera-
peutic protein preparations and blood plasma. Having in
mind the task of developing a sorption-based approach
to endotoxin elimination, we studied the kinetics and
dynamics of endotoxin interactions with hydrophobic
sorbents having different structures.
Endotoxin is classified as a pyrogen, i.e., an agent
able to produce fever. Chemically, endotoxin is an
oligomer consisting of three fragments having differ-
ent structures and functions: a lipid (Lipid A), an
O-polysaccharide (O antigen), and an oligosaccharide
linker (Fig. 1) [4].
LPS elimination standards include strict require-
ments to residual LPS concentrations. WHO Pharma-
copoeias stipulate that LPS levels in intravenous drug
forms must not exceed 0.05 ppm. Higher levels are
known to increase the risk of septic shock [5].
Comparing the currently available approaches to
LPS elimination as to their residual LPS levels suggests
that sorption is what most likely provides the best re-
sults. As to plasmapheresis, multiple repetitions of the
elementary sorption act are seamlessly accommodated
in this therapeutic procedure [6].
Therefore, the most rational approach to reaching the
objective defined above is to develop a selective and ef-ficient (i.e. having a high equilibrium distribution coeffi-
cient, Kd) sorbent for endotoxin entrapping. The matrix
of choice for a sorbent must ensure proper immobiliza-
tion and accessibility of the affine agent and effective
internal diffusion of LPS.
With regards to the blocks composing LPS
molecules, the following should be taken into consid-
eration:
• the O-related hydrophilic portion of LPS is abso-
lutely unproductive in the sense of the effectiveness
of sorption;
• the core of LPS is adsorbable, but it cannot ensure an
acceptable selectivity and Kd above 5;
• the lipid (non-variable) portion of LPS provides for
a highly specific sorption in biologically relevant hy-
drophilic systems and is suitable for the selective en-
trapping of LPS. Similar conclusions are drawn from
computer-assisted modeling of LPS sorption [7].
The experimental hydrophobic sorbent Spherocel
S80 tested in the present work is derived from re-
generated microporous cellulose microspheres. The hy-
drophobic affine moieties of the sorbent are, in essence,
functional analogues of the aliphatic portion of LPS
and, therefore, feature a high affinity to it.
It has been shown [8] that the reduction factor (Kr) of
LPS equilibrium concentration in saline is 1800 to 3000
at the initial LPS concentrations ranging from 10 to
10000 ng/mL. Under the same conditions supplemented
with 10% albumin, Kr decreases to 50–280. This ef-
fect is probably caused by the competition of the two
ligands for binding sites. The maximal capacity of
the sorbent for LPS competed by albumin is 37,000
ng/mL. Kr allows estimating the degree of LPS de-
crease, including the maximum decrease, in a model
medium. The maximal capacity defines the effective-
ness of using a sorbent at very high albumin levels in a
medium.
Experiments have shown that, for chromatography
with Spherocel S80, the losses of the target protein are
within 5% [8], whereas with Polymyxin B Sepharose
the losses are above 25% [4].
One of the pivotal characteristics of the performance
of a sorbent is its hydrodynamic rigidity, which limits
the flow rate in chromatography. This is especially im-
portant for hemosorption. Therefore, the hydrodynamic
resistance of Spherocel was evaluated, and the condi-
tions of its granules after hydrodynamic stress were as-
sessed. The hydrodynamic characteristics were studied
in vitro using a Packard mass-exchange instrument. The
results are presented in Fig. 2.
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Fig. 1. Generic structure of bacterial lipopolysaccharide. Hep—heptose; Kdo—2-keto-3-deoxyoctonic acid; Glcn—N-acetylglucosamine; P—
phosphate; I and II—the polysaccharide and lipid components; I (1)—O-specific chain (highly variable domain); I (2)—outer core (moderately
variable domain); I (3)—inner core (low-variability domain); II (A)—lipid A (almost invariable domain).
Fig. 2. The hydrodynamic characteristics of Spherocel S80 upon in vitro perfusion with 0.9% NaCl solution at different values of the hydrodynamic
coefficient (torr): 0.33 (1), 0.43 (2), and 0.65 (3). Experimental conditions: 1—empty column; 2, 3—column filled with Spherocel and perfused
downward from the top or upward from the bottom, respectively.The linear flow rate of perfusion was derived from
the volumetric rate of filtration and the cross-section
area of a column and found to be 30 mL/cm2 in the
above experiment. To determine the maximal achiev-
able flow rate, Spherocel S80 with a 500 to 800 µm par-
ticle size was loaded into a 50-mL glass column and per-
fused with a 0.9% NaCl solution at flow rates from 100
to 400 mL/min. At flow rates below 300 mL/min, the
flow was uniform. Above 300 mL/min, pulsatile flow
was observed suggesting transition to non-stationary
conditions, although the mean flow rate remained as in-
dicated. Thus, Spherocel S80 was found to preserve ac-
ceptable hydrodynamic characteristics at flow rates up
to 300 mL/min.
Because Spherocel S80 is intended to be applied
to non-Newtonian liquids, such as blood plasma, spe-
cial consideration was given to its deformability and
strength. After sorbent withdrawal from a column, sor-
bent granules were examined by microscopy. No de-
formed or destroyed granules were found.
A peculiar feature of Spherocel S80 is that the dis-
tribution of its pore sizes is bimodal. Its transport-
ing pores are sized from 0.1 to 3.0 µm, whereas its
entrapping pores are sized from 5 to 30 nm. The totalvolume of the transporting and the entrapping pores is
0.8–0.9 and 0.35–0.40, respectively.
The abundance of the transporting pores provides
for the effectiveness of mass transfer of molecular
species having large sizes through the grains of the
sorbent, whereas hydrophobic affine moieties destroy
LPS aggregates by competition for binding with LPS
molecules. Such a structure of the sorbent matrix makes
it possible to effectively entrap species ranging from
single molecules to bulky molecular aggregates with-
out losses in sorbent capacity. This feature is important
when it comes to species as big as LPS aggregates.
The characteristics of endotoxin interactions with the
hydrophobic sorbent under flow conditions were stud-
ied using chromatographic columns of different sizes.
The effects of the rate and duration of perfusion on
LPS binding by Spherocel S80 were evaluated. For this,
a chromatographic column was filled with 20 mL of
Spherocel S80 (125 to 315 µm grain size) and perfused
with a recirculating aqueous 10 ng/mL endotoxin solu-
tion for 1.5 h at 1 mL/sec. The total volume of the per-
fusate passed through the column was 500 mL. Every
10 minutes a 100-µL sample of the perfusate was taken
for analysis. A colorimetric LAL test [9] was used to
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Fig. 3. LPS concentration vs. perfusion time upon the passage of an
LPS solution, which initially had 10 ng/mL LPS, through a Spherocel
S80 column at the rate of 1 mL/s.
Fig. 4. The comparison of the effectiveness of Spherocel S80 (1) and
a polystyrene-divinylbenzene copolymer-based sorbent (2) in extract-
ing LPS from a mixed solution of 100 ng/mL endotoxin and 10%
serum albumin. The plots are similar to those in Fig. 3.determine the endotoxin. The results presented in Fig. 3
show that endotoxin concentration decreased more than
40-fold under the above conditions.
Sorption of endotoxin competed by serum albumin
for binding was studied using a 5-mL chromatographic
column filled with 2 mL of Spherocel S80 with a
500 µm grain size. The column was perfused with 500
mL of a 100 ng/mL endotoxin in a 10% aqueous so-
lution of human serum albumin. The flow rate was
controlled with a peristaltic pump and was chosen to
match requirements to extracorporeal blood treatment
(120 mL/min). The experiment was carried out at a con-
stant temperature. Samples were taken in 20 minutes
for 2 hours. A colorimetric LAL test [9] was used to
measure the endotoxin. The results presented in Fig. 4(curve 1) suggest that 120 minutes of such perfusion en-
sure a 5.7-fold decrease in endotoxin concentration.
For comparison, a similar experiment with a
domestically developed hydrophobic polystyrene-
divinylbenzene hemosorbent resulted in a 3.9-fold
decrease in LPS (Fig. 4, curve 2).
To sum up, Spherocel S80 can decrease LPS con-
centration 40-fold when used under conditions typical
for the final purification of gene-engineered prepara-
tions and more than 5-fold under conditions typical for
extracorporeal blood treatment.
Spherocel S80’s selectivity, capacity, and hydrody-
namic characteristics ensure its usability under flow
conditions and make it competitive, in comparison with
conventional sorbents, with regard to reaching the re-
quired degree of LPS elimination from biotechnological
preparations and biological liquids.
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